PTPI - יחס חוב להיוון בספרים Petros Pharmaceuticals Inc

Heavy pressure from generics and digital services is increasing the debt risks of Petros Pharmaceuticals (PTPI), which, when reviewing the history of debt-to-capitalization ratios on GURU.Markets, is evident in the value of 0.00. Optimization is possible through closed B2B contracts with pharmacies and transitioning drugs to over-the-counter status, despite strict FDA oversight and current instability in the customer base.

Petros Pharmaceuticals is investing in eco-friendly drug synthesis and zero-waste technologies. This indicator measures the proportion of debt relative to equity, neutralizing the time lag of quarterly reporting. A declining curve indicates strengthening financial stability, whereas an increase signals over-leverage. By analyzing the ratio of financial liabilities to book capitalization, the investor assesses liquidity risk. The trend of the line determines the balance between conservatism and growth rates.